Search results (204)
« Back to NewsOxford researchers support international response to Bundibugyo virus disease outbreak
30 Jul, 2026
Teams from across the University of Oxford are supporting the international response to the current Bundibugyo virus disease outbreak through interdisciplinary research spanning biomedical, public health and social and behavioural science.
Smoking and drinking exacerbate social inequalities in premature deaths in India
25 Jun, 2026
Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.
New Lancet review calls for urgent action to tackle the growing global threat of encephalitis
19 Jun, 2026
The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.
Drought linked to 46% increase in sexual violence among adolescents in Southern Africa
18 Jun, 2026
Study reveals climate change is increasing risks to child safety.
Oxford launches interdisciplinary centre to advance women's mental health research globally
17 Jun, 2026
The University of Oxford is set to launch a new research centre dedicated to women’s mental health, bringing together expertise from medical and biological sciences with humanities for the first time.
New Lancet series shows how thousands of maternal deaths could be prevented each year
12 Jun, 2026
Every 12 minutes, somewhere in the world, a woman dies from excessive bleeding after birth (postpartum haemorrhage or PPH). Yet according to a new three-part Lancet Series, led by researchers from the University of Oxford, most of these deaths should never happen.
UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases
29 May, 2026
A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.
Decentralising disease surveillance and modelling approaches will support equitable infectious disease responses
29 May, 2026
By sharing data analytics instead of raw data, federated approaches enable surveillance and modelling while respecting ethical and legal boundaries.
Wearable GPS data expands understanding of schistosomiasis transmission
22 May, 2026
Proximity to unsafe water strongly predicts schistosomiasis exposure, explaining sharp differences in infection and re‑infection across communities.
New study improves early detection of life-threatening infection in children across South and South East Asia
6 May, 2026
A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.
New study highlights promising non-invasive approach to endometriosis diagnosis and monitoring
29 Apr, 2026
A new Oxford-led study highlights the potential of a molecular imaging agent used alongside non-invasive scanning to improve the diagnosis and monitoring of endometriosis - a condition affecting an estimated 190 million women worldwide where delayed diagnosis remains a significant women's health challenge.
New rabies vaccine could provide protection for adults and children with a single dose
29 Apr, 2026
A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.
Expert Comment: World Malaria Day 2026 - Malaria vs the Data Collective
27 Apr, 2026
Malaria is one of the world’s oldest known diseases, but it is a modern disease too - it continues to kill roughly 600,000 people each year. Most of these people are children, living in Sub-Saharan Africa.
University of Oxford and Serum Institute of India agree licence to advance the next-generation multi-stage malaria vaccine candidate component
25 Apr, 2026
The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), a Cyrus Poonawalla group company and the world’s largest vaccine manufacturer by volume, have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.
From Kilifi to the World: Rethinking Malaria Control Through Three Decades of Research
25 Apr, 2026
Since 1995, the KEMRI–Wellcome Trust Research Programme has quietly reshaped the global fight against malaria, not through a single breakthrough, but through a sustained commitment to evidence, context and people. Its work offers a powerful lesson: defeating malaria is not just about tools, but about understanding systems, adapting strategies and investing in local science. This is a thought leadership piece by Professor Isabella Oyier, Head of Bioscience, KEMRI-Wellcome
Innovative housing design cools homes, saves lives in Africa
22 Apr, 2026
New housing designs that reduce indoor temperatures and improve ventilation can help cut infectious disease and improve health outcomes in sub-Saharan Africa, according to new Oxford-led research.
Reimagining community mental health in Kenya through the 'Nyumba Kumi' model
8 Apr, 2026
Community-based approaches like the Nyumba Kumi model highlight how locally embedded partnerships can address mental health challenges in low-resource settings.
Collaboration with the Nepal Public Health Foundation explores maternal health and epilepsy
26 Mar, 2026
A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.
Blood test may improve survival of childhood cancer in Africa
23 Mar, 2026
A simple blood test could speed up diagnosis and improve outcomes for children with Africa’s most common childhood cancer.
Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate
17 Mar, 2026
The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate. Professor Brian Angus is Chief Investigator of the trial.